Tommaso Cassano
Tommaso Cassano
Verified email at unifg.it
TitleCited byYear
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6102005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6102005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6102005
Aberrant insulin signaling in Alzheimer's disease: current knowledge
G Bedse, F Di Domenico, G Serviddio, T Cassano
Frontiers in neuroscience 9, 204, 2015
1582015
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors
MG Morgese, T Cassano, V Cuomo, A Giuffrida
Experimental neurology 208 (1), 110-119, 2007
1542007
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery
A Trapani, E De Giglio, D Cafagna, N Denora, G Agrimi, T Cassano, ...
International journal of pharmaceutics 419 (1-2), 296-307, 2011
1322011
Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model
I Branchi, I D'Andrea, M Armida, T Cassano, A Pèzzola, RL Potenza, ...
Journal of neuroscience research 86 (9), 2050-2061, 2008
1062008
Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model
I Branchi, I D'Andrea, M Armida, T Cassano, A Pèzzola, RL Potenza, ...
Journal of neuroscience research 86 (9), 2050-2061, 2008
1062008
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin
S Gaetani, J Fu, T Cassano, P Dipasquale, A Romano, L Righetti, ...
Journal of Neuroscience 30 (24), 8096-8101, 2010
982010
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
A Seillier, T Advani, T Cassano, JG Hensler, A Giuffrida
International Journal of Neuropsychopharmacology 13 (3), 373-386, 2010
912010
Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes …
T Antonelli, MC Tomasini, M Tattoli, T Cassano, S Tanganelli, S Finetti, ...
Cerebral Cortex 15 (12), 2013-2020, 2005
852005
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus
FR Bambico, T Cassano, S Dominguez-Lopez, N Katz, CD Walker, ...
Neuropsychopharmacology 35 (10), 2083, 2010
842010
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
T Cassano, G Serviddio, S Gaetani, A Romano, P Dipasquale, S Cianci, ...
Neurobiology of aging 33 (6), 1121. e1-1121. e12, 2012
802012
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats
V Trezza, P Campolongo, T Cassano, T Macheda, P Dipasquale, ...
Psychopharmacology 198 (4), 529-537, 2008
792008
Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
L Trabace, T Cassano, L Steardo, C Pietra, G Villetti, KM Kendrick, ...
Journal of Pharmacology and Experimental Therapeutics 294 (1), 187-194, 2000
762000
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
S Gaetani, P Dipasquale, A Romano, L Righetti, T Cassano, D Piomelli, ...
International review of neurobiology 85, 57-72, 2009
722009
PRECLINICAL STUDY: Perinatal exposure to delta‐9‐tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and …
P Campolongo, V Trezza, T Cassano, S Gaetani, MG Morgese, M Ubaldi, ...
Addiction biology 12 (3‐4), 485-495, 2007
562007
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
T Cassano, S Gaetani, T Macheda, L Laconca, A Romano, MG Morgese, ...
Psychopharmacology 214 (2), 465-476, 2011
552011
Cannabinoid receptor agonist WIN 55,212‐2 inhibits rat cortical dialysate γ‐aminobutyric acid levels
L Ferraro, MC Tomasini, T Cassano, BW Bebe, A Siniscalchi, ...
Journal of neuroscience research 66 (2), 298-302, 2001
542001
Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers
C Pomara, T Cassano, S D'Errico, S Bello, AD Romano, I Riezzo, ...
Current medicinal chemistry 19 (33), 5647-5657, 2012
532012
The system can't perform the operation now. Try again later.
Articles 1–20